MyFinsight
Home
Compare
About
Recent SEC Filings
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$56,454K
EPS
-$705.2
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
49,225
39,802
16,043*
35,052
General and administrative
10,962
6,377
-17,767*
14,129
Total operating expenses
60,187
46,179
-1,724
49,181
Gain from operations
-60,187
-46,179
1,724*
-49,181
Interest income
3,551
3,944
1,011*
3,444
Income from transition services agreements
196
223
-1,838*
1,010
Change in fair value of participation right liability
0
0
725*
0
Other income (expense)
-14
-94
55*
-30
Total other income, net
3,733
4,073
-1,497*
4,424
Net gain
-56,454
-42,106
227
-44,757
Basic EPS
-705.2
-526.11
0.012
-1.03
Diluted EPS
-705.2
-526.11
0.012
-1.03
Basic Average Shares
80,054,000
80,032
18,798,465
43,491,085
Diluted Average Shares
80,054,000
80,032
18,798,465
43,491,085
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
BBOT Income Statement Sankey Diagram
Sankey diagram visualizing BBOT income statement for the period
Interest income
$3,551K
Income from transition
services agreements
$196K
Net gain
-$56,454K
Total other income,
net
$3,733K
Other income
(expense)
-$14K
Gain from operations
-$60,187K
Total operating
expenses
$60,187K
Research and development
$49,225K
General and
administrative
$10,962K
Buy us a coffee
BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc. (BBOT)